DMD results, page-3

Wow, stock is getting hammered after hours now. I will be very interested to dig into the PH3 data once it's released. Their PH2 data looked promising, showing stabilization of many muscle functions for more than a year vs. expected declines (not to mention the MRI data showing less fat content in the muscles) yet the PH3 data showed no statistical significant change vs. placebo. Reminds me how binary these biotech investments can be... It simply could've been placebo effect at play in PH2.

PH2 results can be found in their IR presentation below.
http://ir.catabasis.com/static-files/aa37baf4-542c-4272-a970-e40ae99eab3a